Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Routine surveillance systems for pertussis often suffer from under-recognition and under-reporting.
Aim: Our aim was to describe the epidemiology and the clinical features of pertussis in children younger than 1 year in an Italian region, detected through an enhanced hospital surveillance system.
Methods: From 2016 to 2019, we monitored the incidence and the clinical characteristics of hospitalised pertussis cases younger than 1 year in two paediatric hospitals involved in the PERTINENT project.
Results: We detected 141 pertussis cases, corresponding to an estimated incidence of 105.8 per 100.000 in 2016, 91.7 per 100.000 in 2017, 64.5 per 100.000 in 2018 and 40.9 per 100.000 in 2019, based on the hospitals’ catchment area, roughly corresponding to the Lazio region. A total of 101 cases (77.1%) had a household member with cough or other respiratory symptoms. The most frequent combination of symptoms was paroxysmal cough with apnoea in the absence of fever. Almost 40% had been prescribed an antibiotic treatment before hospitalisation, and the median time from symptom onset to contact with the hospital was 8 days. Thirty-one (22.0%) had complications.
Conclusion: An enhanced surveillance system showed a high incidence of pertussis among infants in the Lazio region, where the impact of this disease may still be underestimated. Increasing the coverage of pertussis immunisation among pregnant women and improving the capacity for early detection in primary care may contribute to reducing the impact of pertussis among infants.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212589 | PMC |
| http://dx.doi.org/10.2807/1560-7917.ES.2021.26.24.2000562 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A PEDIATRIC HEALTH PROBLEM INCREASING WITH MIGRATION: PERTUSSIS RELOADING.
Int J Infect Dis
September 2025
Chief of Department of Pediatrics, University of Health Sciences, Mersin City Education and Research Hospital, Turkey. Electronic address:
Objective: Bordetella pertussis is a highly contagious respiratory infection affecting infants, particularly those in vulnerable populations. This study investigates the increase in pertussis cases following refugee influxes and natural disasters.
Methods: This retrospective study analyzed 28 infants hospitalized in our hospital's pediatric ward due to whooping cough between December 27, 2023, and April 30, 2024.
Assessing immunization coverage in Southern togo: implications for perennial malaria chemoprevention delivery.
BMC Public Health
September 2025
Research Institute for Sustainable Development (IRD) EMR 271, University of Bordeaux, National Institute for Health and Medical Research (INSERM), UMR 1219, Bordeaux Population Health Research Centre, Bordeaux, France.
Background: Malaria remains a major health challenge in sub-Saharan Africa, especially for children under five. The World Health Organization (WHO) recommends perennial malaria chemoprevention (PMC) to children in areas of medium to high perennial transmission. In Togo, since 2022, a pilot project has leveraged the Expanded Program on Immunization (EPI) to deliver PMC to children under two years; however, the extent to which PMC achieves its desired outcome may depend on EPI performance.
View Article and Find Full Text PDFin hospitalised children and adolescents: the impact of vaccination delay, Tuscany, Italy, 2016 to 2024.
Euro Surveill
August 2025
Meyer Children's Hospital, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Florence, Italy.
BACKGROUNDPertussis is a highly contagious respiratory infection caused by . Vaccination against pertussis is included in the Italian vaccination programme with three doses administered at 3, 5 and 11 months, booster doses at 6 and 12-18 years, and every 10 years. Vaccination coverage in Tuscany is high among infants (97.
View Article and Find Full Text PDFInterplay between maternal Tdap and infant pneumococcal vaccination in shaping infant pneumococcal vaccine serotype carriage.
J Infect Dis
August 2025
Centre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.
Background: Tetanus, Diphtheria and acellular Pertussis (Tdap) vaccination during pregnancy blunts the infant humoral immune response following primary immunization with pneumococcal conjugate vaccines (PCVs). While this effect typically resolves after the booster dose for most vaccine serotypes, its impact on nasopharyngeal carriage of pneumococcal vaccine serotypes remains unclear.
Methods: A total of 3,298 nasopharyngeal swabs were collected from infants aged 6-30 months attending daycare centers in Belgium between 2018 and 2022, along with data on maternal Tdap vaccination status (clinicaltrials.
Contextualizing future maternal RSV vaccination acceptance and trust among pregnant and lactating women in Kenya: A latent class analysis.
PLOS Glob Public Health
August 2025
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Maternal vaccination, or vaccination in pregnancy, offers a critical opportunity to provide protection to pregnant women and simultaneously confer passive immunity to infants in the first months of life, when infections are particularly serious and their immune systems are still developing. Respiratory syncytial virus (RSV) is one such serious infectious disease for newborns, but a newly approved and recommended vaccine for respiratory syncytial virus has been designed to be given to pregnant women to protect their newborns from severe RSV disease when they are most vulnerable. While maternal vaccination has been used for tetanus, pertussis, influenza, COVID-19, and other diseases, vaccination in pregnancy can present unique challenges related to hesitancy and delivery, particularly in lower-resourced settings.
View Article and Find Full Text PDF